The global gene therapy market is projected to grow at a CAGR of 27%-29% during 2020-2025. The growth of Gene therapy market is driven by increasing government support for R&D activities, rising awareness of people towards gene therapy, and increasing prevalence of cancer.
Some of the Key Questions answered in this exclusive report are:
Q.1 What are some of the
most promising, high-growth opportunities for the gene therapy market by gene
type (antigen, cytokine, tumor suppressor, suicide, deficiency, growth factors,
receptors, and others), application (oncological disorders, rare diseases,
cardiovascular diseases, neurological disorders, infectious disease, and other
diseases), vector (non-viral vectors (oligonucleotides and other non-viral
vectors) and viral vectors (retroviral vectors, adeno-associated virus vectors,
and other viral vectors)), indication (neurological diseases, cancer,
hepatological diseases, duchenne muscular dystrophy, and other indications),
delivery method (in vivo gene therapy and ex vivo gene therapy), and region (North
America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will
grow at a faster pace and why?
Q.3 What are the
business risks and threats to the gene therapy market?
Q.4 What are some
changing demands of customers in the gene therapy market?
Q.5 What are the new
developments in the gene therapy market? Which companies are leading these
developments?
Q.6 What strategic
initiatives are being implemented by key players for business growth?
Q.7 What are some of the
competitive products and processes in this gene therapy area and how big of a
threat do they pose for loss of market share via product substitution?
Q.8 What M&A
activity has occurred in the last 5 years in this gene therapy market?
Download Brochure of this report by clicking on https://www.lucintel.com/gene-therapy-market.aspx
Market Segmentation:
Based on vector, the gene
therapy market is segmented into non-viral vectors (oligonucleotides and other
non-viral vectors) and viral vectors (retroviral vectors, adeno-associated
virus vectors, and other viral vectors). The non-viral vectors segment is accounted
for the largest share of the market in 2020 due to increasing demand of oligonucleotide-based non-viral vector
gene therapies and advancements in physicochemical approaches for gene
therapies during preclinical and clinical trials.
North America is expected
to be the largest region over the forecast period due to high disposable
incomes, increasing prevalence of chronic diseases, and growing healthcare
expenditure in the region.
Key Players in the gene therapy
market are Biogen, Novartis AG, Gilead Sciences, Spark Therapeutics, MolMed
S.p.A., Orchard Therapeutics, SIBIONO, Shanghai Sunway Biotech, bluebird bio,
and Human Stem Cells Institute.
Request Sample Pages by clicking on https://www.lucintel.com/gene-therapy-market.aspx
The report helps stakeholders understand the
pulse of the market and provides them with information on key drivers,
restraints, challenges, and opportunities for market growth. It would also help
to understand the competitors better and gain more insights to improve their
position in the business.
To read more about this market please click on
https://www.lucintel.com/gene-therapy-market.aspx
About
Lucintel
Lucintel,
the premier global management consulting and market research firm, creates
winning strategies for growth. It offers market assessments, competitive
analysis, opportunity
analysis, growth
consulting, M&A, and due diligence services to executives and
key decision-makers in a variety of industries. For further information, visit www.lucintel.com.
Brandon
Fitzgerald
Lucintel
Dallas,
Texas, USA
Email: brandon.fitzgerald@lucintel.com
Tel. 972.636.5056
Cell: 303.775.0751
Related reports
Surgical
Instrument Tracking System Market:
For more details click here https://www.lucintel.com/surgical-instrument-tracking-system-market.aspx
Metabolomics
Market:
For more details click here https://www.lucintel.com/metabolomics-market.aspx
Industrial Microbiology Market:
For more details click here https://www.lucintel.com/industrial-microbiology-market.aspx
Surgical Microscope Market:
For more details click here https://www.lucintel.com/surgical-microscope-market.aspx
Tumor Ablation Market:
For more details click here https://www.lucintel.com/tumor-ablation-market.aspx
Vitamin D Market:
For more details click here https://www.lucintel.com/vitamin-d-market.aspx
Urology
Device Market:
For more details click here https://www.lucintel.com/urology-device-market.aspx
Halal Ingredient Market:
For more details click here https://www.lucintel.com/halal-ingredient-market.aspx
Gene
Expression Market:
For more details click here https://www.lucintel.com/gene-expression-market.aspx
GMO Testing Market:
For more details click here https://www.lucintel.com/gmo-testing-market.aspx
No comments:
Post a Comment